The adoption of vegan and vegetarian diets in the teen years can trigger concerns over nutritional deficiencies and disordered eating. But new reports indicate few problems when these diets are followed correctly.

In a recent study, female offspring of mothers with a positive COVID-19 test during pregnancy were at a decreased risk of developing neurodevelopmental disorders compared to male offspring.

Leniolisib is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.

An investigation utilizing machine learning (Recursive Ensemble Feature Selection, REFS) identifies potential biomarkers for asthma control in pediatric patients.

New maternal vaccine options could offer extra protection in upcoming seasons.

In children who are subject to migraine attacks, vitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate, results of a study in Saudi Arabia showed.

Pediatric patients with BRAF V600E low-grade glioma as young as 1 year can now be treated with dabrafenib plus trametinib following its FDA approval.

A recent survey from the C.S. Mott Children’s Hospital National Poll on Children’s Health revealed how addictive parents believe vaping is for children.

All children included in the analysis achieved swallowing, oral nutrition, and airway protection outcomes.

Exposure to a common seasonal coronavirus stimulates a memory T cell response that protects children against COVID-19. However, this immune response peaks at age 6.

Recent data revealed a 110% increase in speech disorder diagnoses for children aged 0 to 12 years in 2022, compared to the pre-pandemic era.

In a recent review, children with vaccination against human papillomavirus (HPV) initialized at a younger age were more likely to receive their full vaccination series.

In identical phase 3 trials, roflumilast demonstrated topline positive results, reducing itch in children and adults with mild to moderate AD.

As little as 39 minutes less sleep per night for 1 week can have an impact on the quality of life of children.

Evkeeza is the first angiopoietin-like 3 (ANGPTL3) inhibitor indicated for patients as young at 5 years to control high levels of low-density lipoprotein cholesterol (LDL-C) as a result of HoFH.

In a phase 3 clinical trial, dupilumab met both its primary and key secondary endpoints, demonstrating efficacy as a potential treatment for atopic hand and foot dermatitis.

Built environments, but not social and economic environments, were negatively associated with BMI and overweight or obesity status, with a stronger association among adolescents with longer exposure to their built environment.

This commentary describes the story of Kimberly Coffey and the role pediatric/adolescent practitioners play in the prevention of invasive meningococcal meningitis by discussing with parents, adolescents, and young adults the value of accepting the meningitis B vaccine (MenB).

A study found that children with acute concussions could have less symptom burden with an earlier return to school.

The infant formula giant recalls one of their powdered infant formula products out of an abundance of caution for a potentially dangerous bacteria.

In a recent study, reductions in body mass index along with further beneficial effects were found when using oral butyrate supplementation for treating pediatric obesity.

At the 44th National Association of Pediatric Nurse Practitioners Conference, drug products abused by teenagers were discussed.

According to a recently published study, identification of early initiation and quick escalation to high-intensity drinking in adolescents and young adults can increase screenings for these types of behaviors.

At the 44th National Association of Pediatric Nurse Practitioners Conference, methods of treating atopic dermatitis were discussed.

A recent study indicated that lebrikizumab treatment for 16 weeks was effective for adolescents and adults with moderate-to-severe atopic dermatitis.